The Swiss Stock Exchange opened on a slightly positive note on Monday, carried by the hope of advances on the thorny file of customs duties. While business news was idling, investors will have significant macroeconomic data to analyze this week.
In the United Kingdom, reduced customs duties on exports from the automotive and aerospace sectors to the United States came into force on Monday. The Canadian government announced on Sunday to cancel a tax targeting technology giants in the hope of reaching a trade agreement with Washington. President Donald Trump had ended the discussions because of this tax.
While the deadline of July 9 for entry into force for customs duties in the EU and Switzerland is approaching, “hope is great” that these prices “are not introduced,” said Jochen Stanzl, CMC Markets analyst. “In the best case, the European Union provisionally accepts the general customs duties of 10%, in order to continue negotiations beyond July 9,” he detailed.
In addition to the evolution of the trade war, the speakers will scrutinize this Monday inflation in June in Germany and economic growth in the United Kingdom in the first quarter. Inflation in the euro zone in June and Thursday will follow the unemployment rate in the United States on Tuesday and consumer prices in Switzerland the same month.
In Switzerland, economic prospects are deteriorating. After a slight increase in the previous month, the KOF cyclical barometer has reached its lowest level since the start of the year.
Shortly before 9:10 am, the SMI star index rose painfully by 0.17% to 12,002.02 points, after closing on Friday 0.84%. The SLI earned 0.21% at 1972.35 points and the SPI took 0.15% at 16,631.95 points.
A majority of star values ​​appeared in the green, worn by Partners Group (+1.5%), Schindler (+0.9%) and UBS (+0.8%). UBS analysts have lowered the price of the Zugois asset manager, but confirmed their recommendation for purchase. The Lacernois elevator manufacturer took advantage of a raising of courses and also a confirmation to “Buy” by Jefferies.
The three keys Bank will launch a new two -year share buy -back program aimed at acquiring up to $ 2 billion in titles. This should start on July 1.
Roche (stable) recorded two departures in its extended management. The other two heavy goods vehicles on the Novartis (-0.2%) and Nestlé (+0.5%) side left in opposite directions.
At the other end of the table were SIG Group (-1.8%), Swatch Group (-1.4%) and Sika (-0.4%). The Biennese watchmaker paid the price of a lowering lens by UBS. Analysts from the Zurich bank also confirmed their recommendation for sale.
On the extended market, Galderma (-2.1%) saw its recommendation planed at “Neutral”, against “buy” previously, by UBS.
Forbo (-3.8%) took note of the start of the year of his treasurer Andreas Jaeger, who acts incidentally as acting managing director since February.
Addex (+2.0%) will invest 2 million francs in its Swiss counterpart Stalicla, notably developing treatments for autism spectrum disorder (TSA).
Idorsia (+7.7%) recorded a step success in the development of a new generation vaccine. The first clinical data on this experimental prophylactic treatment suggest good tolerability and a favorable safety profile, in addition to inducing an antigenic reaction against the Difficult Clostridium bacteria and its spores.
Leonteq (Stable) will offer a “significant” reduction in the remuneration of members of its board for the 2026 financial year during an extraordinary general meeting. (Awp)
